Niti Aayog Planning to Improve Indian Medical Devices Sector | Drugdu.com



New Delhi: National Information for Transforming India (policy think tank of the government of India) (NITI AAYOG), yesterday held a meeting to improve the production of the medical device products in India, the experts conducted the meeting to estimate on tax-based incentives and caps on distributor and retailer margins of medical devices products. The meeting was attended by senior government officials from different ministries as well as industry representatives.
Niti Aayog is focusing on proposals to encourage domestic manufacturing of medical device products following orders from the Prime Minister's Office, said the expert. The meeting was focused on identifying the problems in local manufacturing and quality of the devices produced in India and also to spot the solution for the issues.
"This was a routine meeting to discuss how India can have a complete ecosystem with respect to law, import duties and infrastructure (to incentivize local manufacturing)," said expert. "Incentives like tax reduction and providing land at reasonable prices were also discussed." In addition, it discussed to caps on trade margins to level down prices of medical device products as opposed to capping their maximum retail prices
India's medical devices sector is fixed at a $5.2 billion (Rs35, 097.40 crores), show government estimates. Closely 70% of the country's medical devices requirement is met through imports, according to industry estimates.
Source:http://drugducom.blogspot.com/2018/06/niti-aayog-planning-to-improve-indian.html


评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - interstitial lungdiseases resulting in the
阅读全文

Consumption of Crickets Support the Growth of Beneficial Gut Bacteria

图片
Valerie Stull, a doctoral graduate from the University of Wisconsin-Madison Nelson Institute for Environmental Studies published the results of her study on the benefits of consuming crickets on gut bacteria in the journal  Scientific Reports.  It is not only safe at high doses but may also reduce inflammation in the body Valerie Stull said that she was 12 when she ate her first insect. She said,  “I was on a trip with my parents in Central America and we were served fried ants; I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food — and it was good!” Stull further added,  “There is a lot of interest right now in edible insects; It’s gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock.” Tiffany Weir, the co-corresponding author and a professor of food science and human nutrition at Colorado State University said,  “Thi
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to
阅读全文